http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220155085-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87d40fb4785f5b3f1a4dba8c69339d1a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b1d73a56a6950b0d8913fb609de611f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f97cb58f9a3e6225719568a4f0d6d8d |
| publicationDate | 2022-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20220155085-A |
| titleOfInvention | Bile-derived miRNA biomarker for diagnosing bile duct cancer and uses thereof |
| abstract | The present invention relates to bile-derived miRNA biomarkers and their uses for diagnosing cholangiocarcinoma. When using the miRNA biomarker derived from exosomes in the bile of the present invention, cholangiocarcinoma can be diagnosed with the same or better accuracy than when tissue-derived miRNA is used. It can be used effectively in information provision methods for In addition, because of the higher stability of non-coding RNA in exosomes than in bodily fluids, genetic analysis through exosomes may be better than assays in bile itself. |
| priorityDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.